Why is "Allergan, Inc." trending?
Latest news, Wikipedia summary, and trend analysis.
Trend Analysis
- Ranking position: #
- Date: 2026-06-02 09:46:20
This topic has appeared in the trending rankings 1 time(s) in the past year. While it does not trend frequently, its appearance suggests a renewed or concentrated surge of public interest.
Based on Wikipedia pageviews and search interest, this topic gained significant attention on the selected date.
Trend Insight
Allergan,_Inc. entered the ranking for the first time today at position #. This is its highest position ever recorded.
Trend History
This topic has appeared in the English Wikipedia rankings 1 time. It first appeared on 2026-06-02 and was most recently seen on 2026-06-02.
Wikipedia Overview
Allergan, Inc. was an American global pharmaceutical company focused on eye care, neurosciences, medical dermatology, medical aesthetics, breast enhancement, obesity intervention and urologics. Allergan, Inc. was formed in 1948, incorporated in 1950 and became a public company in 1970. It ceased operation in 2015 when it was acquired by Irish-based Actavis plc, who then renamed the group as Allergan plc.
Read more on Wikipedia →Related Topics
Trending Topic Today
Search Interest Perspective
-
Allergan Files Suits Against Imprimis Pharmaceuticals, Inc., Prescriber's Choice, Inc., and Sincerus Florida, LLC - PR Newswire
-
Allergan | AGN Stock Price, Company Overview & News - Forbes
-
CAFC Overturns $39 Million Jury Verdict, Finds Allergan Hair Loss Patent Invalid for Lack of Written Description - IPWatchdog.com
-
Allergan – History, Products, Recalls, Lawsuits & Other Facts - Drugwatch.com
-
Allergan picks up Repros to boost women’s health offerings - BioPharma Dive
-
Allergan Gets Dismissal of Whistleblower’s Botox Kickback Suit - Bloomberg Law News
-
Local deputies arrest ‘poster boy’ for Allergan, Inc., in child sex solicitation probe - KWTX
-
ALLERGAN INC. | Dollars for Docs - ProPublica
-
The World's Biggest Generic Drug Maker Just Got Bigger - Time Magazine
-
Allergan Inc. Release: New Survey Reveals What Women In The U.S. Really Want To Know About BOTOX® Cosmetic (onabotulinumtoxina) - BioSpace
-
EXHIBIT 99.2 - SEC.gov
-
Botox rival Revance loses bid to dismiss Allergan trade secrets lawsuit - reuters.com
-
Moran Eye Center's Voyant Biotherapeutics, LLC, Enters Into Exclusive R&D Collaboration Agreement with Allergan, Inc. - University of Utah Health
-
Allergan fights back: Botox maker reportedly pursuing Salix; stocks up - Los Angeles Times
-
How Allergan went from a tiny Los Angeles eye care company to the biggest takeover target of 2015 - Business Insider
-
AbbVie to Acquire Allergan in Transformative Move for Both Companies - PR Newswire
-
AbbVie unit wins $56 mln in US patent trial against Botox rival - reuters.com
-
Allergan Inc. Layoffs: Employees Tell Their Side Of The Story - BioSpace
-
Actavis Completes Allergan Acquisition - PR Newswire
-
Valeant ready to raise Allergan bid to at least $200/share - reuters.com
-
Allergan recalls textured breast implant tied to rare cancer - 13wham.com
-
LifeCell not liable, jurors rule in Strattice mesh hernia lawsuit - The Indiana Lawyer
-
Pershing Square, Valeant to Pay $290 Million to End Lawsuit - Bloomberg.com
-
Award-winning Actress Courtney Thorne-Smith and Allergan, Inc. Reveal Changes in Women's Perceptions of BOTOX Cosmetic Over Nearly a Decade - PR Newswire
-
Allergan buys SkinMedica for $350 million - Orange County Register
-
Tarsus Pharmaceuticals Appoints Renowned Biopharmaceutical - globenewswire.com
-
FDA initiates nationwide recall of 2.5M prednisolone acetate eye drops - Glance by Eyes On Eyecare
-
Allergan Fights to Keep Botox-Making Process Secret From Rival - Bloomberg.com
-
ALASTIN™ Skincare, Inc. Announces Appointment of Lynn Salo to Company's Board of Directors - PR Newswire
-
Spark: Tim Terrell – senior vice president, Drug Safety Evaluation, Allergan Inc., Irvine - Orange County Register
-
AbbVie Gets FDA Approval for New Antibiotic in the Face of Rising Resistance - BioSpace
-
Actavis Still Eyes ‘Couple Billion Dollar’ Deals After Allergan - Bloomberg.com
-
Allergan plans hundreds of OC jobs - Orange County Register
-
Graham Rhys Obituary - Toms River, NJ - Dignity Memorial
-
FDA panels put silicone breast implants back under microscope - CNN
-
Allergan Breast Implant Lawsuit | Potential Links to BIA-ALCL - Drugwatch.com
-
How Ackman Hopes to Beat Insider-Trading Lawsuit: QuickTake Q&A - Bloomberg.com
-
When Viagra Met Botox: Pfizer, Allergan Eye Mega-Merger - Fortune
-
A ‘Better Botox’ May Target Millennials, Men and Hesitant Women - Bloomberg.com
-
FDA holds off Allergan migraine drug - Orange County Register
-
Canada's Valeant to buy Salix in $10.1 billion deal - reuters.com
-
Canadian class-action lawsuit launched against popular breast implant brand - Daily Hive
-
B+L owner Valeant plans hostile bid for Allergan - Democrat and Chronicle
-
Plaintiffs Seek Cert. in SkinMedica Skin Cream Class Action Lawsuit - Top Class Actions
-
Federal Court identifies loophole in Canadian Patent Act - Fasken
-
Allergan hits back, launches poison pill against hostile Valeant takeover - The Globe and Mail
-
No more wrinkles: High Court clarifies reputation principle for trade mark infringement in PROTOX dispute - Corrs Chambers Westgarth
-
Allergan Botox Patent Fight Set for Trial in July in Delaware - USA Herald
-
BOTULISM ILLNESS MARKET 2023 REPORT OVERVIEW BY TOP KEY PLAYERS - openPR.com
Why This Topic Is Trending
This topic has recently gained attention due to increased public interest. Search activity and Wikipedia pageviews suggest growing global engagement.
Search Interest & Related Topics
Search interest data over the past 12 months indicates that this topic periodically attracts global attention. Sudden spikes often correlate with major news events, public statements, or geopolitical developments.